Medunik USA strengthens Pheburane® (sodium phenylbutyrate) coverage under Medicaid Programs

PRINCETON, N.J., Nov. 4, 2025 /PRNewswire/ - Medunik USA, a specialty pharmaceutical company dedicated to providing rare disease patients with access to orphan drugs, and part of Duchesnay Pharmaceutical Group (DPG), winner of the 2024 Life Sciences Innovation Award by ADRIQ, is pleased...